Flat ₹100 OFF on First app order | Use Code: APP100 |
Flat ₹100 OFF
on First app order
Use Code
APP100
Download Now
100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine
Salt Composition in bothDoxorubicin (Plain) 50mg
Duxocin 50mg Powder for Injection
You Searched
Duxocin 50mg Powder for Injection
Biochem Pharmaceutical Industries
₹894.3
Our Recommendation
Doxotero 50mg Injection
10+ trust this
WHO GMP Certified
WHO GMP
Certified
Long Expiry
(>8 Months)
WHO GMP
Certified
Long Expiry
(>8 Months)
Delivery by
Used In
Cancer
Customers also bought
More About Duxocin
Benefits
In Cancer Duxocin 50mg Powder for Injection helps to treat certain kinds of cancer. It may be used alone or in combination with other medicines to treat cancer in various parts of the body. Duxocin 50mg Powder for Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is a potent and very toxic medicine and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol while having this treatment and drink plenty of water to stay hydrated.
Side Effects
The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you're worried about them.
How to use
Your doctor or nurse will give you this medicine. Kindly do not self administer.
How it works
Duxocin 50mg Powder for Injection is an anti-cancer medication. It works by suppressing the activity of an enzyme (topoisomerase II) involved in DNA multiplication of the cancer cells. It also forms harmful chemicals (free radicals) which cause DNA damage. This slows the growth of cancer cells and eventually kills them.
Consult your Doctor: Please consult your doctor regarding the safety of consuming alcohol with Duxocin 50mg Powder for Injection . Experts have not found evidence of alcohol impairing the effectiveness of the medicine.
Seek medical advice from your doctor: Duxocin 50mg Powder for Injection is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Doctor consultation is advised.
Not Safe: Duxocin 50mg Powder for Injection is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Not Safe: Duxocin 50mg Powder for Injection may cause side effects which could affect your ability to drive. As there is a frequent occurrence of nausea and vomiting with Duxocin 50mg Powder for Injection so driving should be discouraged.
Safe when prescribed by an expert: Duxocin 50mg Powder for Injection is safe to use in patients with kidney disease. No dose adjustment of Duxocin 50mg Powder for Injection is recommended. However, inform your doctor if you have any kidney disease.
Caution Advised: Duxocin 50mg Powder for Injection should be used with caution in patients with liver disease. Dose adjustment of Duxocin 50mg Powder for Injection may be needed. Doctor consultation is advised.
Manufacturer Address
BIOCHEM PHARMA, LG 113 / A, Xth Central Mall, Mahavir Nagar, 90ft Road, Next to D Mart, Kandivali - West, Mumbai - 400067.
References
Chabner BA, Bertino J, Cleary J, et al. Cytotoxic Agents. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilmans: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1714-15
Chu E, Sartorelli AC. Cancer Chemotherapy. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 952
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 431-33
Doxorubicin hydrochloride. Sandwich, Kent: Pfizer Limited; 2009 (25 Jan. 2019)
Chaves RG, Lamounier JA. Breastfeeding and maternal medications. J Pediatr (Rio J). 2004;80(5 Suppl):S189-S198 (19 Mar. 2019)
Central Drugs Standard Control Organisation (CDSCO) (27 Mar. 2019)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
